Clinical Trials in Atlanta

Showing 5261-5280 of 14,993 trials

Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure

NCT04352205

This phase II trial studies how well daratumumab-based therapy works in treating patients with newly diagnosed multiple myeloma with kidney failure. Daratumumab-based therapy includes daratumumab, bortezomib, dexamethasone, and thalidomide or lenalidomide. Daratumumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Bortezomib is a drug that prevents myeloma cells from getting rid of their waste products, leading to being targeted for death. Dexamethasone is a steroid that is commonly used, either alone or in combination with other drugs, to treat multiple myeloma. Lenalidomide and thalidomide may stop the growth of multiple myeloma by blocking the growth of new blood vessels necessary for tumor growth. Giving daratumumab, bortezomib, dexamethasone, and thalidomide or lenalidomide may be a good way to treat patients with newly diagnosed multiple myeloma with kidney failure.

Plasma Cell MyelomaRenal Failure

Emory University17 participantsStarted May 2020

Atlanta, Georgia, United States

COMPLETEDPhase 1< 1 mile

A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia

NCT05848700

A Clinical Study to learn if SEP-363856 has physical dependence in adults with schizophrenia. This study will be held in approximately 6 study sites in the United States. It will be accepting male and female participants age 18 years to 65 years. Participation will be up to approximately10 weeks.

Schizophrenia

Otsuka Pharmaceutical Development & Commercialization, Inc.60 participantsStarted Jun 2023

Little Rock, Arkansas, United States • Rogers, Arkansas, United States • Miami Lakes, Florida, United States +4 more locations

Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure

A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia

Find Trials by Condition in Atlanta

Psychotherapy for PTSD Among Veterans Also Receiving Drug or Alcohol Treatment

Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®

Teaching Loved Ones to Help Veterans Optimize Their PTSD Care and Healing

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

Efficacy of Human Placental Graft in Diabetic Foot Ulcers

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout

A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)